AIM Biotech
  • HOME
    • ABOUT US
    • CAREERS
    • NEWSROOM
  • TECHNOLOGY
    • TECHNOLOGY
    • APPLICATIONS
    • PUBLICATIONS
  • PRODUCTS
    • CHIPS
    • ACCESSORIES
    • RESEARCH SERVICES
  • PROTOCOLS
    • GENERAL PROTOCOLS
    • APPLICATION-SPECIFIC PROTOCOLS
    • VIDEOS
    • PROTOCOL SUBMISSION
  • SUPPORT
    • CONTACT US
    • FAQ
    • TIPS & TRICKS
    • BROCHURES
    • APPLICATION NOTES
    • FORUMS
  • STORE
    • DISTRIBUTORS

MIT News features AIM Biotech

16/8/2015

0 Comments

 
Picture
Read the full MIT News article here. Images from AIM were also featured as the spotlight story (main image) of MIT's homepage for August 17th 2015.
0 Comments

AIM Biotech Launches Its First Products for 3D Cell Culture

8/8/2015

0 Comments

 
AIM Biotech is making available its first 3D cell culture device, DAX-1, to R&D customers around the world. Designed as an easy-to-use, modular platform, the chip enables cell biologists to develop biological models incorporating 3D structures such as microvasculature and cancer cell spheroids. The core technology was developed by Professor Roger D. Kamm et al. at the Massachusetts Institute of Technology (MIT) & the Singapore-MIT Alliance for Research & Technology (SMART), and has been used in angiogenesis, metastatic cancer, neuroscience and stem cell research. AIM Biotech has made the technology accessible to researchers by designing the products to work in typical cell biology laboratories. Learn more at www.aimbiotech.com.
0 Comments

    Archives

    January 2020
    December 2019
    November 2018
    October 2018
    August 2018
    July 2018
    April 2018
    November 2017
    July 2017
    April 2017
    December 2016
    July 2016
    March 2016
    January 2016
    December 2015
    September 2015
    August 2015

    Categories

    All

    RSS Feed

Picture
About AIM Biotech
Contact Us
Newsroom
Subscribe to AIM Biotech's mailing list

This website and its content is copyright of AIM Biotech Pte. Ltd.
​© AIM Biotech Pte. Ltd. 2020. All rights reserved.